SLAMF1-deficient cells are resistant to drugs that activate autophagy, and these results indicate that SLAMF1 expression potentially affects drug responses in chronic lymphocytic leukemia [35]. The gene discussed is SLAMF1; the disease is B-cell chronic lymphocytic leukemia.